ESC 365 - Rivaroxaban and stroke events in patients with heart failure, sinus rhythm, and coronary disease: the COMMANDER-HF trial

HFA Premium Access

Rivaroxaban and stroke events in patients with heart failure, sinus rhythm, and coronary disease: the COMMANDER-HF trial

Session: Late breaking trial II - Chronic heart failure

Topic: Pharmacotherapy

Speaker: Doctor M. Vaduganathan (Boston, US)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

39 presentations

15 followers

12 more presentations in this session

Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial

Speaker: Professor M. Schulz (Berlin, DE)

Discussion - PHARM-CHF

Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure

Speaker: Professor P. Rossignol (Monaco, MC)

Discussion - AMBER.

Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Speaker: Doctor A. Biolo (Porto Alegre, BR)

Access the full session

Late breaking trial II - Chronic heart failure

Speakers: Doctor M. Vaduganathan, Professor M. Schulz, Professor P. Rossignol, Doctor A. Biolo

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources